RxDoctor Payments Data

Jerome Carolino, MD

Family Medicine · Summerfield, FLNPI 1134176464

Payments from drug & device makers

$762in general payments, 2019–2025

Across 45 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$155
  • Amgen$124
  • GSK$112
  • AstraZeneca$63
  • Amarin Pharma, Inc.$61
  • Johnson & Johnson$54
  • plus $194 from 11 others

What the payments were for

  • Food & beverage$762100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$762 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$12,552
Medicare patients
32
Services billed
135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter71$100,766
EliquisApixaban114$67,274
JardianceEmpagliflozin67$58,610
OzempicSemaglutide33$40,582
TradjentaLinagliptin31$34,406
FarxigaDapagliflozin Propanediol32$30,687
JanuviaSitagliptin Phosphate18$20,596
XareltoRivaroxaban15$16,976
EntrestoSacubitril/Valsartan11$16,045
Tresiba Flextouch U-200Insulin Degludec13$14,149
MounjaroTirzepatide12$13,134
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$12,752
Gabapentin256$5,727
Albuterol Sulfate HfaAlbuterol Sulfate179$5,066
Atorvastatin Calcium536$4,635

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$112$100,76671 claims
Boehringer IngelheimJardiance, Tradjenta$14$93,01698 claims
PfizerEliquis$19$67,274114 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$63$47,49261 claims
Novo NordiskOzempic, Fiasp$155$44,92147 claims
Johnson & JohnsonXarelto$54$16,97615 claims
NovartisEntresto$13$16,04511 claims
Lilly USA, LLCMounjaro$19$13,13412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Summerfield

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →